Journal for ImmunoTherapy of Cancer (Nov 2023)

678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial

  • Wei Wang,
  • Mo Wang,
  • Zhiming Li,
  • Xiaoming Huang,
  • Siyang Wang,
  • Chuan Jin,
  • Hao Jiang,
  • Xudong Wang,
  • Ye Guo,
  • Zhendong Li,
  • Desheng Hu,
  • Guochun Cao,
  • Song Qu,
  • Youhua Zhu,
  • Meiyu Fang,
  • Wantao Chen,
  • Chuanzheng Sun,
  • Jingfeng Zong,
  • Jinguan Lin,
  • Minghua Ge,
  • Xianming Luo,
  • Shuanghui Wei,
  • Yuteng Shen

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0678
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.